Methotrexate in Early Pregnancy — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Start high-dose folic acid and refer to maternal-fetal medicine
Methotrexate is a potent teratogen (folate antagonist) associated with aminopterin syndrome. It should have been stopped ≥3 months before conception. With early exposure and immediate cessation, outcomes may be acceptable, but high-dose folic acid (5 mg daily) and urgent referral to maternal-fetal medicine for counselling and detailed fetal anomaly assessment is essential. Individual risk assessment is needed.
Reference: EULAR – 2024 – Medications in Pregnancy; TGA 2024